Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-24-032896
Filing Date
2024-08-16
Accepted
2024-08-16 17:30:39
Documents
12

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 2648598
2 ex10-37.htm EX-10.37 203701
3 ex10-38.htm EX-10.38 16085
4 ex10-39.htm EX-10.39 16093
5 ex10-40.htm EX-10.40 15733
6 ex23-1.htm EX-23.1 4007
7 logo_003.jpg GRAPHIC 4863
8 chart_002.jpg GRAPHIC 220685
9 chart_022.jpg GRAPHIC 273662
10 logo_001.jpg GRAPHIC 3581
11 GRAPHIC image_001.jpg GRAPHIC 631
12 GRAPHIC image_002.jpg GRAPHIC 630
  Complete submission text file 0001493152-24-032896.txt   3600165
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-274805 | Film No.: 241217722
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)